Holen Sie sich die Stockscreener-App
26.72
1.91%
0.50
Handel nachbörslich:
25.65
-1.07
-4.00%
Schlusskurs vom Vortag:
$26.22
Offen:
$26.43
24-Stunden-Volumen:
391.78K
Relative Volume:
0.41
Marktkapitalisierung:
$2.91B
Einnahmen:
$322.71M
Nettoeinkommen (Verlust:
$-298.33M
KGV:
-6.5171
EPS:
-4.1
Netto-Cashflow:
$-218.98M
1W Leistung:
+1.48%
1M Leistung:
+1.87%
6M Leistung:
+48.44%
1J Leistung:
-7.35%
1-Tages-Spanne:
$25.96
$27.33
1-Wochen-Bereich:
$25.71
$27.48
52-Wochen-Spanne:
$13.48
$36.60
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Firmenname
Zai Lab Limited Adr
Sektor
Branche
Telefon
862161632588
Adresse
4560 JINKE ROAD, SHANGHAI
Vergleichen Sie ZLAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
26.72 | 2.91B | 322.71M | -298.33M | -218.98M | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-21 | Eingeleitet | Macquarie | Outperform |
| 2021-10-12 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-04-15 | Eingeleitet | Guggenheim | Buy |
| 2019-07-12 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-05 | Eingeleitet | Macquarie | Outperform |
| 2019-01-29 | Eingeleitet | Credit Suisse | Outperform |
| 2018-11-21 | Eingeleitet | Jefferies | Buy |
| 2018-06-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Eingeleitet | JP Morgan | Neutral |
| 2017-10-16 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten
BNP Paribas Financial Markets Has $31,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Announces Participation in Investor Conference in January 2025 - Business Wire
Janus Henderson Group PLC Increases Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Bamco Inc. NY Increases Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Stocks to Watch Monday: Stellantis, Tesla, Intel, Super Micro - The Wall Street Journal
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer - Business Wire
Daiwa Securities Group Inc. Purchases 9,364 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Algert Global LLC Makes New Investment in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
(repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List - Business Wire
The week in pharma: action, reaction and insight – week to November 22 - The Pharma Letter
Is Enviri Corp (NYSE: NVRI) A Good Pick For New Investors Now? - Stocks Register
Can Controladora Vuela Cia De Aviacion ADR (NYSE: VLRS) Be A Safe Investment Now? - Stocks Register
Zai Lab Grants Share Units to Employees - Marketscreener.com
Connor Clark & Lunn Investment Management Ltd. Acquires 125,532 Shares of Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics - MSN
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares - BioSpace
ZLABZai Lab Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan
Zai Lab Raises $230M in Oversubscribed Public Offering of American Depositary Shares - StockTitan
FY2024 EPS Estimates for Zai Lab Increased by Analyst - Defense World
Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume – Here’s What Happened - Defense World
Digital Brands Group Inc (DBGI): Is It Worth A Small Bite At $0.10? - Stocks Register
Thermo Fisher Scientific Inc’s (TMO) Stock Is Harder To Predict Than You Think - Stocks Register
Selling Your MicroAlgo Inc (NASDAQ: MLGO) Stock? Here’s What You Need To Know - Stocks Register
Danaher Corp (DHR): An Important Analyst Insights - Stocks Register
Centerpoint Energy Inc (NYSE: CNP): Blank Check On Growth? - Stocks Register
Do Unitedhealth Group Inc (NYSE: UNH) Provide Stability And Growth? - Stocks Register
Major Improvements In VF Corp (VFC) Stock Need To Be Considered - Stocks Register
A Stock Analysis Of Fortive Corp’s (FTV) - Stocks Register
Dollar Tree Inc’s (DLTR) Stock Is Harder To Predict Than You Think - Stocks Register
BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register
Leerink Partnrs Increases Earnings Estimates for Zai Lab - Defense World
Zai Lab Announces $200M Public Offering at $25.50 per ADS | ZLAB Stock News - StockTitan
Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire
Janus Henderson Group's Strategic Acquisition of Zai Lab Shares - GuruFocus.com
Zai Lab Announces Proposed Public Offering of American Depositary Shares - Business Wire
Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Zai Lab Ltd (ZLAB) Reports Q3 2024 Earnings: EPS Loss of $0.04, Revenue at $101.8 Million, Slightly Misses Estimates - GuruFocus.com
abrdn Life Sciences Investors declares $0.50 dividend - MSN
Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for - GlobeNewswire
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Business Wire
Zai Lab (ZLAB) Scheduled to Post Quarterly Earnings on Tuesday - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
JP Morgan analysts reiterates an Overweight rating for Roku Inc (ROKU) - Knox Daily
Is Patterson Companies Inc (NASDAQ: PDCO) A Suitable Stock For New Investors Today? - Stocks Register
Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China - Business Wire
Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.7% – Here’s What Happened - Defense World
Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - MSN
Biopharma operator Zai Lab surges to 16-month high on lung cancer drug trial results - Mugglehead
Trial highlights potential next-gen biologic for lung cancer - Marketscreener.com
Zai Lab (NASDAQ:ZLAB) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Finanzdaten der Zai Lab Limited Adr-Aktie (ZLAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):